COVID‐19 convalescent plasma: phase 2

See editorial on page 1123–1127, in this issue

Saved in:
Bibliographic Details
Published inTransfusion (Philadelphia, Pa.) Vol. 60; no. 6; pp. 1332 - 1333
Main Authors Knudson, C. Michael, Jackson, J. Brooks
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.06.2020
Wiley Subscription Services, Inc
Subjects
Antibodies, Viral - blood
Betacoronavirus - immunology
Blood Component Transfusion - methods
Blood Donors
Convalescence
Coronavirus Infections - immunology
Coronavirus Infections - therapy
Coronavirus Infections - virology
COVID-19
Humans
Pandemics
Plasma - immunology
Pneumonia, Viral - immunology
Pneumonia, Viral - therapy
Pneumonia, Viral - virology
Practice Guidelines as Topic
SARS-CoV-2
Treatment Outcome
United States
United States Food and Drug Administration
United States
Online AccessGet full text

Cover

More Information
Summary:See editorial on page 1123–1127, in this issue
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0041-1132
1537-2995
DOI:10.1111/trf.15842